| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,765 |
2,341 |
$134K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
161 |
110 |
$8K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
141 |
106 |
$6K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
259 |
232 |
$6K |
| 87428 |
|
55 |
52 |
$3K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
28 |
26 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15 |
15 |
$1K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
14 |
12 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
28 |
16 |
$989.24 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
28 |
26 |
$782.50 |
| 87999 |
|
47 |
45 |
$738.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
46 |
42 |
$722.20 |
| 96127 |
|
16 |
13 |
$233.60 |
| 94760 |
|
27 |
25 |
$118.80 |
| 3074F |
|
740 |
630 |
$0.00 |
| 1160F |
|
1,552 |
1,268 |
$0.00 |
| 3078F |
|
688 |
586 |
$0.00 |
| 1159F |
|
1,552 |
1,268 |
$0.00 |
| 3210F |
|
15 |
15 |
$0.00 |
| 99072 |
|
156 |
134 |
$0.00 |